Highlights
- Cipla shares rose 0.09% to close at INR 1,440.10 in latest session.
- Company reported consolidated net profit of INR 54,251.00 lakh for March 2026 quarter.
- Stock remains below its 52-week high of INR 1,673.00 despite recent recovery.
Cipla Limited (NSE:CIPLA), listed on the National Stock Exchange (NSE) under the pharmaceuticals sector, closed at INR 1,440.10 on June 25, 2026, registering a marginal gain of INR 2.20 or 0.15% from the previous close.
The stock opened at INR 1,448.00 and moved within a narrow range during the session, touching an intraday high of INR 1,453.00 and a low of INR 1,431.00. The Volume Weighted Average Price (VWAP) stood at INR 1,443.75, slightly above the closing level.
Source: Analysis by Kalkine
Trading Activity and Market Position
Cipla recorded traded volume of 12.18 lakh shares with a traded value of INR 175.80 crore during the session. The impact cost remained low at 0.02, indicating strong liquidity conditions in the counter.
The company’s total market capitalisation stood at INR 1,16,265.10 crore, while free-float market capitalisation was INR 80,748.09 crore. Deliverable quantity accounted for 57.33% of total traded volume, reflecting a balanced mix of investor participation.
Stock Performance Across Time Frames
Cipla has shown mixed performance compared to the NIFTY 50 index.
Over the past week, the stock gained 6.47%, significantly outperforming the index, which rose 0.18%. On a one-month basis, Cipla gained 1.53% versus the index gain of 0.60%. Year-to-date performance shows a decline of 4.11%, while the NIFTY 50 index fell 8.00%, indicating relative outperformance.
Over a one-year period, the stock declined 4.93%, compared with a 5.84% fall in the index. Longer-term performance includes gains of 40.84% over three years and 50.37% over five years. The stock is currently trading well below its 52-week high of INR 1,673.00 (23-Oct-2025) and above its 52-week low of INR 1,165.70 (02-Apr-2026).
Financial Performance Overview
For the quarter ended March 31, 2026, Cipla reported standalone total income of INR 4,39,020.00 lakh. Standalone profit before tax stood at INR 52,248.00 lakh, while net profit was INR 38,464.00 lakh. Earnings per share (EPS) was INR 4.76.
On a consolidated basis, total income stood at INR 6,68,936.00 lakh. Profit before tax was INR 70,706.00 lakh, while net profit reached INR 54,251.00 lakh. Consolidated EPS was INR 6.87.
Valuation and Market Position
Cipla is part of the NIFTY 50 index and operates in the Pharmaceuticals industry. The stock’s P/E ratio stands at 30.06, with an adjusted P/E of 28.40.
The stock continues to show moderate volatility at an annualised level of 27.51, reflecting relatively stable price movement compared with broader market fluctuations.
Key Risks
- Pricing pressure in global generics market may affect margins.
- Regulatory approvals in key export markets may delay product launches.
- Currency fluctuations can impact overseas revenue realization.
- Competitive intensity in pharma segment may limit growth momentum.
Summary
Cipla Limited (NSE:CIPLA) shares closed marginally higher at INR 1,440.10 on June 25, 2026, reflecting a stable trading session. The company reported consolidated net profit of INR 54,251.00 lakh for the March 2026 quarter, while the stock continues to trade below its 52-week high despite moderate recovery trends.
FAQs
Q: What was Cipla’s closing price on June 25, 2026?
A: Cipla closed at INR 1,440.10 after a marginal gain of 0.09% in the session.
Q: What was Cipla’s consolidated net profit for March 2026 quarter?
A: The company reported consolidated net profit of INR 54,251.00 lakh for the quarter.
Q: How has Cipla performed compared to NIFTY 50 index?
A: Cipla outperformed the index year-to-date despite a 4.11% decline versus index fall.